Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
415 studies found for:    "Hemophilia A"
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor
Conditions: Hemophilia A;   Hemophilia B;   (High-titer) Factor VIII Inhibitor;   (High-titer) Factor IX Inhibitor
Intervention: Biological: Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)
2 Recruiting An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
Conditions: Hemophilia A;   Severe Hemophilia A
Intervention: Biological: rVIII‑SingleChain
3 Completed A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia A With Inhibitors;   Haemophilia B;   Haemophilia B With Inhibitors
Intervention: Drug: eptacog alfa (activated)
4 Completed
Has Results
Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A
Condition: Hemophilia A
Intervention: Biological: OBI-1
5 Terminated
Has Results
Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A
Condition: Hemophilia A
Intervention: Biological: OBI-1
6 Suspended Study of Ataluren (PTC124®) in Hemophilia A and B
Conditions: Hemophilia A;   Hemophilia B
Intervention: Drug: Ataluren (PTC124)
7 Not yet recruiting Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A
Condition: Hemophilia A
Intervention: Drug: ADVATE
8 Terminated Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A
Condition: Hemophilia A
Interventions: Drug: Rituxan;   Drug: prednisone
9 Completed Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A
Conditions: Prophylaxis;   Hemophilia A
Intervention: Other: prophylaxis treatment, on demand treatment
10 Completed Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients
Condition: Hemophilia A
Intervention: Drug: FVIII
11 Not yet recruiting Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A
Condition: Hemophilia A
Intervention: Drug: Recombinant Human Coagulation Factor VIII for injection
12 Completed Clot Formation and Clot Stability in Patients With Severe Haemophilia A
Condition: Hemophilia A
Intervention: Drug: ReFacto (Recombinant factor VIII) and Tranexamic acid
13 Active, not recruiting PK Driven Prophylaxis for Hemophilia A
Condition: Hemophilia A
Intervention: Device: MyPKFiT
14 Completed Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
Condition: Hemophilia A
Intervention: Drug: GreenGene
15 Recruiting Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients
Condition: Hemophilia A
Intervention: Drug: Plasma-derived FVIII/VWF concentrate
16 Completed Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients
Condition: Haemophilia A
Intervention: Drug: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
17 Active, not recruiting Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A
Condition: Hemophilia A
Intervention: Biological: BAY94-9027
18 Recruiting Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients
Conditions: Hemophilia A;   Factor VIII
Intervention: Drug: Recombinant VIII factor
19 Completed
Has Results
Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A
Conditions: Blood Coagulation Disorders;   Hemophilia A
Interventions: Biological: Recombinant Factor VIII (BAY81-8973);   Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
20 Active, not recruiting Inhibitor Development in Patients With Hemophilia A Undergoing Surgery
Condition: Hemophilia A
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years